Increase in QT/QTc dispersion after low energy cardioversion of chronic persistent atrial fibrillation

International Journal of Cardiology

Volumn 95, Issue 2-3, 2004, Pages 245-250

  Boriani, Giuseppe ^a   Valzania, Cinzia ^a   Biffi, Mauro ^a   Corazza, Ivan ^a   Camanini, Claudia ^a   Martignani, Cristian ^a   Bacchi, Letizia ^a   Zannoli, Romano ^a   Branzi, Angelo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Atrial cardioversion; Atrial fibrillation; QT dispersion; Repolarization

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; FEMALE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART RIGHT ATRIUM; HUMAN; MALE; PRIORITY JOURNAL; QT DISPERSION; SINUS RHYTHM;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHRONIC DISEASE; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED;

EID: 2942522891     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.05.022     Document Type: Article

References (35)

1. Lown B. Electrical reversion of cardiac arrhythmias. Br. Heart J. 29:1967;469-489
2. Ewy G.A. Optimal technique for electrical cardioversion of atrial fibrillation. Circulation. 86:1992;1645-1647
3. Boriani G., Biffi M., Camanini C., Luceri R.M., Branzi A. Transvenous low energy internal cardioversion for atrial fibrillation: a review of clinical applications and future developments. Pacing Clin. Electrophysiol. 24:2001;99-107
4. Mittal S., Ayati S., Stein K.M., et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation. 101:2000;1282-1287
5. Oral H., Souza J.J., Michaud G.F., et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pre-treatment. N. Engl. J. Med. 340:1999;1849-1854
6. Ayers G.M., Alferness C.A., Ilina M., Wagner D.O., Sirokman W.A. Ventricular proarrhytmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Circulation. 89:1994;413-422
7. Ayers G.M. New concepts in atrial defibrillation. J. Interv. Cardiol. Electrophysiol. 4(Suppl. 1):2000;155-161
8. Santini M., Pandozi C., Altamura G., et al. The efficacy of high- and low-energy intracavitary cardioversion in chronic atrial fibrillation refractory to transthoracic cardioversion. G. Ital. Cardiol. 28:1998;788-796
9. Levy S., Ricard P., Lau C.P., et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J. Am. Coll. Cardiol. 29:1997;750-755
10. Day C.P., McComb J.M., Campbell R.W. QT dispersion: an indication of arrhythmias risk in patients with long QT intervals. Br. Heart J. 63:1990;342-344
11. Higham P.D., Campbell R.W. QT dispersion. Br. Heart J. 71:1994;508-510
12. Hii J.T., Wyse D.G., Gillis A.M., Duff H.J., Solylo M.A., Mitchell L.B. Precordial QT interval dispersion as a marker of Torsade de Pointes. Circulation. 86:1992;1376-1382
13. Pye M., Quinn A.C., Cobbe S.M. QT interval dispersion: a non-invasive marker of susceptibility to arrhytmia in patients with sustained ventricular arrhytmias? Br. Heart J. 71:1994;511-514
14. Boriani G., Biffi M., Bronzetti G., et al. Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am. J. Cardiol. 81:1998;241-244
15. Sun Z.H., Swan H., Viitasalo M., Toivonen L. Effects of epinephrine and phenilephrine on QT interval dispersion in Congenital Long QT syndrome. J. Am. Coll. Cardiol. 31:1998;1400-1405
16. Choy A.M., Darbar D., Dell'Orto S., Roden D.M. Exaggerated QT prolongation after cardioversion of atrial fibrillation. J. Am. Coll. Cardiol. 34:1999;396-401
17. Benn M., Hansen P.S., Pedersen A.K. QT dispersion in patients with arrythmogenic right ventricular dysplasia. Eur. Heart J. 20:1999;764-770
18. Gurevitz O., Yaacoby E., Segal E., et al. Effect of implantable cardioverter-defibrillator shocks on QT dispersion. Am. J. Cardiol. 86:2000;1146-1148
19. Pinski S.L., Fahy G.J. The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation. 92:1995;1651-1664
20. Glikson M., Friedman P.A. The implantable cardioverter defibrillator. Lancet. 357:2001;1107-1117
21. Behrens S., Li C., Fabritz C.L., Kirchhof P.F., Franz M.R. Shock-induced dispersion of ventricular repolarization: implications for the induction of ventricular fibrillation and the upper limit of vulnerability. J. Cardiovasc. Electrophysiol. 8:1997;998-1008
22. Cooper J.M., Katcher M.S., Orlov M.V. Implantable devices for the treatment of atrial fibrillation. N. Engl. J. Med. 346:2002;2062-2068
23. Houltz B., Darpo B., Swedberg K., et al. Comparison of QT dispersion during atrial fibrillation and sinus rhythm in the same patients, at normal and prolonged ventricular repolarization. Europace. 2:2000;20-31
24. Boriani G., Biffi M., Pergolini F., Bargossi A., Zannoli R., Branzi A. Evaluation of plasma catecholamines during low energy internal atrial cardioversion and during electrophysiological study for induction of ventricular tachyarrhythmias. [Abstr.] Europace. (Suppl. 1:D275):2000
25. James P.R., Taggart P., McNally S.T., Newman S.P., Sporton S.C., Hardman S.M. Acute psychological stress and the propensity to ventricular arrhythmias. Eur. Heart J. 21:2000;1023-1028
26. Timmermans C., Rodriguez L.M., Smeets J.L., Wellens H.J. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J. Cardiovasc. Electrophysiol. 9:1998;122-128
27. Tse H.F., Lau C.P., Ayers G.M. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart. 82:1999;319-324
28. Brendorp B., Elming H., Jun L., et al. QT dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function. Circulation. 103:2001;831-835
29. Wellens H.J., Lau C.P., Luderitz B., et al. Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation. 98:1998;1651-1656
30. Heisel A., Jung J. The atrial defibrillator: a stand-alone device or part of a combined dual-chamber system? Am. J. Cardiol. 83:1999;218D-226D
31. Krol R.B., Saksena S., Prakash A. New devices and hybrid therapies for treatment of atrial fibrillation. J. Interv. Cardiol. Electrophysiol. 4:2000;163-169
32. Lesh M.D., Kalman J.M., Roithinger F.X., Karch M.R. Potential role of hybrid therapy for atrial fibrillation. Semin. Interv. Cardiol. 2:1997;267-271
33. Boriani G., Biffi M., Capucci A., et al. Favorable effects of flecainide in transvenous internal atrial fibrillation. J. Am. Coll. Cardiol. 33:1999;333-341
34. Faber T.S., Kautzner J., Zehender M., Camm A.J., Malik M. Impact of electrocardiogram recording format on QT interval measurement and QT dispersion assessment. Pacing Clin. Electrophysiol. 24:2001;1739-1747
35. Kautzner J., Yi G., Camm A.J., Malik M. Short and long-term reproducibility of QT, QTc, and QT dispersion measurement in healthy subjects. Pacing Clin. Electrophysiol. 17:1994;928-937